Biofil Chemicals and Pharmaceuticals Limited reported earnings results for the fourth quarter and full year ended March 31, 2022. For the fourth quarter, the company reported sales was INR 16.46 million compared to INR 142.39 million a year ago. Revenue was INR 16.76 million compared to INR 142.34 million a year ago. Net loss was INR 0.285 million compared to INR 4.15 million a year ago.
For the full year, sales was INR 223.82 million compared to INR 357.5 million a year ago. Revenue was INR 225.33 million compared to INR 365.5 million a year ago. Net income was INR 6.98 million compared to INR 12.41 million a year ago. Basic earnings per share from continuing operations was INR 0.44 compared to INR 0.77 a year ago. Diluted earnings per share from continuing operations was INR 0.44 compared to INR 0.77 a year ago.